US Patent Issued to Novartis on Oct. 22 for "2-azaspiro[3.4octane derivatives as M4 agonists" (British, American Inventors)

ALEXANDRIA, Va., Oct. 23 -- United States Patent no. 12,122,761, issued on Oct. 22, was assigned to Novartis AG (Basel, Switzerland).

"2-azaspiro[3.4octane derivatives as M4 agonists" was invented by Amy Calhoun (Cambridge, Mass.), Xin Chen (Lexington, Mass.), Kevin Matthew Gardinier (Arlington, Mass.), Edward Charles Hall (Boston), Keith Jendza (Boston), Nancy Labbe-Giguere (Arlington, Mass.), James Neef (Stow, Mass.), Daniel Steven Palacios (Cambridge, Mass.), Ming Qian (Watertown, Mass.), Michael David Shultz (Lexington, Mass.), Christopher G. Thomson (Herts, Great Britain), Kate Yaping Wang (Boxborough, Mass.) and Fan Yang (West Roxbury, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herei...